专利号:US-9315483-B2 优先权日:2007-09-13 标题 :Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof 发明人:JONES ANDREW D; ZELLE ROBERT E; SILVERMAN I ROBERT 权利人:CONCERT PHARMACEUTICALS INC 摘要:The present invention provides a convenient and efficient process for the synthesis of d 2 -benzo[d][1,3]dioxoles.
专利号:US-9884844-B2 优先权日:2012-12-31 标 题:Heterocyclic compounds and methods of use thereof 发明人:FANG QUN KEVIN; CAMPBELL UNA; SPEAR KERRY L 权利人:SUNOVION PHARMACEUTICALS INC; SUNOVION PHARMACEUTICALS INC 摘要:Provided herein are heterocyclyl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. The compounds provided herein are useful for the treatment, prevention, and/or management of various neurological disorders, including but not limited to, psychosis and schizophrenia.
专利号:US-7799829-B2 优先权日:2006-07-28 标 题 :Acyloxyalkyl carbamate prodrugs of α-amino acids, methods of synthesis and use 发明人:DAI XUEDONG; GANGAKHEDKAR ARCHANA; XIANG JIA-NING; GALLOP MARK A 权利人:XENOPORT INC 摘要:Acyloxyalkyl carbamate prodrugs of α-amino acids, pharmaceutical compositions thereof, methods of making acyloxyalkyl carbamate prodrugs of α-amino acids and methods of using acyloxyalkyl carbamate prodrugs of α-amino acids, and pharmaceutical compositions thereof to treat a disease are disclosed. Acyloxyalkyl carbamate prodrugs of α-amino acids suitable for oral administration using sustained release dosage forms are also disclosed.
专利号:EP-4630405-A1 优先权日:2022-12-06 标题 :Process for the synthesis of substituted tetrahydrofuran modulators of sodium channels
专利号:WO-2009035652-A1 优先权日:2007-09-13 标 题 :Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof
专利号:US-5663449-A 优先权日:1989-05-19 标 题 :Intermediate compounds in the synthesis of heteroarylpiperidines, pyrrolidines and piperazines
1: Remezova IP, Lazaryan DS, Voronkov AV, Avramenko NS, Maksimenko TI, Sanzhieva DY. [The chemical toxicological analysis of sertindole]. Sud Med Ekspert. 2016;59(1):35-39. Russian. doi: 10.1016/j.bbr.2016.02.032. Epub 2016 Mar 3. doi: 10.1016/j.saa.2015.08.040. Epub 2015 Sep 1. doi: 10.1097/JCP.0000000000000305. Review. doi: 10.1177/2045125314560738. 6: Nielsen J, Matz J, Mittoux A, Polcwiartek C, Struijk JJ, Toft E, Kanters JK, Graff C. Cardiac effects of sertindole and quetiapine: analysis of ECGs from a randomized double-blind study in patients with schizophrenia. Eur Neuropsychopharmacol. 2015 Mar;25(3):303-11. doi: 10.1016/j.euroneuro.2014.12.005. Epub 2015 Jan 3. doi: 10.1517/14656566.2014.947960. Epub 2014 Aug 1. Review. doi: 10.1177/2045125313499065. 9: Waldman W, Kaletha K, Sein Anand J. [Acute poisoning with sertindole--a case report]. Przegl Lek. 2013;70(8):669-70. Polish. doi: 10.1097/WNF.0b013e3182aa38c4. Review. doi: 10.1093/chromsci/bmt066. Epub 2013 Jun 2. doi: 10.1517/14740338.2013.773971. Epub 2013 Feb 25. Hungarian. doi: 10.1016/j.bmc.2012.10.049. Epub 2012 Nov 15. doi: 10.1517/14740338.2012.726984. Epub 2012 Sep 19. Review. doi: 10.1097/YIC.0b013e328354dcda. doi: 10.1097/JCP.0b013e318248dfb8. doi: 10.1111/j.1600-0447.2012.01840.x. Epub 2012 Feb 22.
合成参考文献
参考文献:10.2147/tcrm.s12701 摘要:Samalin L, Garnier M, Llorca PM. Clinical potential of lurasidone in the management of schizophrenia. Ther Clin Risk Manag. 2011;7():239–50. 参考文献:10.2147/copd.s21071 摘要:Wilson R, Anzueto A, Miravitlles M, Arvis P, Faragó G, Haverstock D, Trajanovic M, Sethi S. A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology. Int J Chron Obstruct Pulmon Dis. 2011;6():373–83. 参考文献:10.3109/08039488.2011.590603 摘要:Lindström E, Eberhard J, Fors BM, Hansen K, Sapin C. A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia in Sweden. Nord J Psychiatry. 2011 Dec;65(6):403–13. doi: 10.3109/08039488.2011.590603. 参考文献:10.4103/0019-5545.82537 摘要:Gautam S, Meena PS. Drug-emergent metabolic syndrome in patients with schizophrenia receiving atypical (second-generation) antipsychotics. Indian J Psychiatry. 2011 Apr;53(2):128–33.